TIDMZIP 
 
28 April 2009 
 
                                 ZONE-IP LTD. 
 
                                  (LSE: ZIP) 
 
                         ("ZONE-IP" OR THE COMPANY") 
 
              FINAL results for the year ENDED 31 December 2008 
 
Chairman's Statement 
 
In the year ended 31 December 2008 the Company incurred a loss on continuing 
operations of $3.9 million (2007: $2.75 million) on turnover of $4.8 million 
(2007: $8.26 million).  As at 31 December 2008, the Company had a cash portfolio 
of $2.9 million (2007: $5.2 million). 
 
During 2008, the Company continued to invest further efforts in the 
development of its products. The Company has dramatically improved 
videoconferencing experience of its products by launching the HD7000Pro, the 
high definition room videoconferencing system. The Company has also released 
the VCBPro7, an all-in-one, high definition Multipoint Control Unit 
(MCU),which the Board believes is the first MCU on the market to deliver 
integrated session-recording and streaming capabilities. The VCBPro7 includes 
an embedded MXM, Emblaze-VCON's award-winning, full-feature management tool 
for video network management and total gateway functionality for legacy and 
advanced technologies. The Company has also begun work on a low-bandwidth 
videoconferencing technology targeted at the satellite-based IP communications 
market to allow video communications in remote regions of the world where 
there is a lack of IP infrastructure. 
 
On the operational side, ZONE-IP's subsidiary, Emblaze-VCON, has implemented 
significant cost reductions in order to adjust to the general economic 
climate. 
 
Future Prospects 
 
The Board expects that demand for video communication via desktop computers 
will increase, specifically in light of the obvious need of organizations to 
reduce costs of sales and traveling expenses. The convergence from legacy 
analog systems into more advanced IP based products is taking place, however, 
at a slower pace than we anticipated. Management will continue to work hard to 
strengthen the Company's position. The board continues to seek ways to further 
save costs and to operate in the most cost efficient way. 
 
Dr Hans Wagner 
 
Chairman 
 
Enquiries: 
 
Zone-IP Ltd. 
Hagit Gal                     +972 9 7699339 
 
John East & Partners Limited 
David Worlidge                + 44 20 7628 2200 
 
 
 
CONSOLIDATED BALANCE SHEETS 
 
                                                        31 December 
 
                                         Note       2008          2007 
 
                                                   $'000         $'000 
ASSETS 
 
CURRENT ASSETS: 
Cash and cash equivalents                          2,316         1,968 
Restricted cash                                       51         1,257 
Short-term available-for-sale marketable  2 
securities                                           526           150 
Trade receivables                         3        1,322         2,383 
Other accounts receivable and prepaid 
expenses                                             252           529 
Inventories                                        2,547         2,730 
 
Total current assets                               7,014         9,017 
 
NON-CURRENT ASSETS: 
Long-term available-for-sale marketable   2 
securities                                             -         1,869 
Property and equipment                               349           397 
Intangible assets                         4          400           650 
 
Total non-current assets                             749         2,916 
 
Total assets                                       7,763        11,933 
 
 
CONSOLIDATED BALANCE SHEETS 
 
                                                      31 December 
 
                                        Note        2008          2007 
 
                                                   $'000         $'000 
LIABILITIES AND EQUITY 
 
CURRENT LIABILITIES: 
Short-term bank credit                             2,282         2,330 
Trade payables                                       882         3,042 
Employees and payroll accruals                       680           515 
Related party                            6            15            53 
Government grants                                    804           767 
Deferred revenues                                     92           203 
Accrued expenses and other liabilities               642           429 
 
Total current liabilities                          5,397         7,339 
 
NON-CURRENT LIABILITIES: 
Government grants                                    480           593 
Employees benefits liability                         356           232 
Loan from related party                  6d        1,032             - 
 
Total non-current liabilities                      1,868           825 
 
Liabilities attributed to discontinued 
operations                                           111           111 
 
Total liabilities                                  7,376         8,275 
 
EQUITY: 
Ordinary shares                                      109           109 
Share premium                                     13,407        13,203 
Net unrealized losses reserve                          -         (139) 
Capital reserve from transaction with    6d 
controlling shareholder                              250             - 
Foreign currency translation reserve                  17             4 
Accumulated deficit                             (13,396)       (9,519) 
 
Total equity                                         387         3,658 
 
Total liabilities and equity                       7,763        11,933 
 
 
 
CONSOLIDATED STATEMENTS OF OPERATIONS 
 
                                                    For the year ended 
                                                        31 December 
 
                                                    2008          2007 
 
                                                   $'000         $'000 
Continuing Operations: 
 
Revenues                                           4,803         8,265 
Cost of revenues                                 (1,961)       (3,294) 
 
Gross profit                                       2,842         4,971 
 
Operating expenses: 
Research and development                           3,052         3,019 
Selling and marketing                              2,044         2,682 
General and administrative                         2,418         1,840 
 
Total operating expenses                           7,514         7,541 
 
Operating loss                                   (4,672)       (2,570) 
Finance income                                       371           594 
Finance costs                                    (1,192)         (832) 
Other income (Note 4)                              1,616             - 
 
Loss for the period from continuing operations   (3,877)       (2,808) 
 
Discontinued Operation: 
 
Income for the period from a discontinued operation    -            85 
 
Net loss for the year                            (3,877)       (2,723) 
 
Loss per share: 
 
Basic and diluted loss per share from 
continuing operations                            $(0.08)       $(0.05) 
Basic and diluted loss per share from a 
discontinued operation                           $(0.00)       $(0.00) 
 
Basic and diluted loss per share                 $(0.08)       $(0.05) 
 
Weighted average number of shares used in 
computing basic and diluted loss per share    51,120,253    51,120,253 
 
 
 
CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY 
 
                                          Capital 
                                          reserve 
                                             from                Foreign 
                                      transaction        Net    currency 
                                             with unrealized translation 
                                      controlling       loss 
                       Share    Share                        adjustments Accumulated     Total 
                     capital  premium shareholder    reserve     reserve     deficit    equity 
 
                       $'000    $'000       $'000      $'000       $'000       $'000     $'000 
 
Balance as of 1                                 - 
January 2007             109   12,989                   (10)         (2)     (6,796)     6,290 
 
Foreign currency 
translation                -        -                      -           6           -         6 
Net loss on 
available- 
for-sale financial 
assets                     -        -                  (129)           -           -     (129) 
Share-based payment        -      214                      -           -           -       214 
Net loss                   -        -           -          -           -     (2,723)   (2,723) 
 
Balance as of 31                                - 
December 2007            109   13,203                  (139)           4     (9,519)     3,658 
 
Foreign currency                                - 
translation                -        -                      -          13           -        13 
Capital reserve 
from 
controlling                                   250 
shareholder's 
loan                       -        -                      -           -           -       250 
Net gain on 
available- 
for-sale financial 
assets                     -        -           -        139           -           -       139 
Share-based payment        -      204           -          -           -           -       204 
Net loss                   -        -           -          -           -     (3,877)   (3,877) 
 
Balance as of 31                              250 
December 2008            109   13,407                      -          17    (13,396)       387 
 
 
 
CONSOLIDATED STATEMENTS OF CASH FLOWS 
 
                                                            Year ended 
                                                            31 December 
 
                                                         2008         2007 
 
                                                        $'000        $'000 
Cash flows from operating activities: 
Net loss                                              (3,877)      (2,723) 
Adjustments to reconcile the net loss to net cash 
used in operating activities: 
 
Income from discontinued operations                         -         (85) 
Depreciation and amortization                             462          522 
Capital gain from sale of intangible assets           (1,616)            - 
Share-based payment                                       204          214 
Increase in employee benefits liability                   124           83 
Impairment of marketable securities                       228            - 
Amortization of premium and discount of 
marketable securities                                      62           41 
Increase in short and long-term Government 
grants payables                                          (76)         (64) 
 
Working capital adjustments: 
Decrease /(increase) in trade receivables               1,061        (722) 
Decrease /(increase) in other accounts receivable 
and prepaid expenses                                      277        (141) 
Decrease /(increase) in inventories                       115      (1,437) 
Increase /(decrease) in trade payables                (2,160)        1,459 
(Decrease) /increase in employees and payroll 
accruals                                                  165        (112) 
Decrease in deferred revenues                           (111)        (268) 
Increase in accrued expenses and other liabilities        213           41 
 
Net cash flows used in continuing operating 
activities                                            (4,929)      (3,192) 
Net cash flows used in discontinued operating 
activities                                                  -         (54) 
 
Net cash used in operating activities                 (4,929)      (3,246) 
 
Cash flows from investing activities: 
Purchase of property and equipment                      (102)         (26) 
Proceeds from sale of intangible assets, net            1,622            - 
Restricted cash                                         1,206      (1,020) 
Investment in marketable securities                     (250)      (2,680) 
Proceeds from sale of marketable securities             1,592        5,970 
 
Net cash provided by investing activities               4,068        2,244 
 
Cash flows from financing activities: 
(Decrease) /increase in short-term bank credit           (48)        1,815 
Loan from related party                                 1,282            - 
Decrease in related party                                (38)        (460) 
 
Net cash provided by financing activities               1,196        1,355 
 
Increase in cash and cash equivalents                     335          353 
Net foreign exchange difference                            13            2 
Cash and cash equivalents at beginning of year          1,968        1,613 
 
Cash and cash equivalents at end of period              2,316        1,968 
 
 
 
CONSOLIDATED STATEMENTS OF CASH FLOWS 
 
                                                            Year ended 
                                                            31 December 
 
                                                         2008         2007 
 
                                                        $'000        $'000 
(1) Supplemental disclosure of cash flow activities: 
 
    Interest received                                     320          302 
 
    Interest paid                                         119           72 
 
    Tax paid                                               15           15 
 
(2) Non-cash activities: 
 
    Transfer from inventories to property and 
    equipment                                              68          114 
 
    Property acquired through suppliers' credit             -           34 
 
    Capital reserve from loan with controlling 
    shareholder                                           250            - 
 
(3) Net cash flows used in discontinued operating 
    activities: 
 
    Profit from a discontinued operation                    -           85 
    Less: decrease in accrued expenses associated 
    with the discontinued operation                         -        (139) 
 
                                                            -         (54) 
 
NOTES TO THE FINANCIAL STATEMENTS 
 
All references to $ are to US Dollars in thousands 
 
NOTE 1:-. The financial information for the year ended 31 December 2007 is 
extracted from the Group's financial statements to that date which received an 
unqualified auditor's report. The financial information for the year ended 31 
December 2008 is extracted from the Group's unaudited financial statements to 
that date. 
 
NOTE 2:- Available-for-sale marketable securities 
 
Short-term available-for-sale marketable securities as of 31 
December 2007 (none in 2008) were all with contractual maturities of less than 
1 year as follows: 
 
                                                       31 
                                                    December 
                                                      2007 
                              Effective 
                               interest  Amortized  Unrealized  Market 
                                   rate       cost      losses   value 
 
                                             $'000       $'000   $'000 
                               3.88 per 
Corporate debentures              cent.        150           -     150 
 
Long-Term Available-for-Sale Marketable securities as of 31 
December, 2008 and 2007 were all with contractual maturities of more than 1 
year as follows: 
 
                                                       31 
                                                    December 
                                                      2008 
                              Effective 
                               interest  Amortized    Realized  Market 
                                   rate       cost      losses   value 
Mature after one year and 
less than five years:                        $'000       $'000   $'000 
 
                               2.28 per 
Corporate debentures              cent.        754       (228)     526 
 
 
                                                        31 
                                                     December 
                                                       2007 
                              Effective 
                               interest  Amortized  Unrealized  Market 
                                   rate       cost      losses   value 
Mature after one year and 
less 
than five years:                             $'000       $'000   $'000 
 
                               5.54 per 
Corporate debentures              cent.      1,407       (144)   1,263 
Foreign bonds denominated in   5.45 per 
U.S. dollar                       cent.        601           5     606 
 
                                             2,008       (139)   1,869 
 
 
During 2008, the Company recorded impairment losses of $ 228,000 
due to the recent credit crisis which impacted the fair value of the Company's 
investments in its available-for-sale marketable securities and caused a 
severe decline in the fair value of its investments. 
 
NOTE 3- Trade Receivables 
 
Trade receivables are non-interest bearing. They are generally on 60-90 credit 
day terms. 
 
                                               31 December 
 
                                           2008          2007 
 
                                          $'000         $'000 
Trade receivables                         1,784         2,514 
Less - allowance for doubtful 
accounts                                  (462)         (131) 
 
Trade receivables, net                    1,322         2,383 
 
 
The movement in the allowance for doubtful accounts is as follows: 
 
                                                Allowance for 
                                                     doubtful 
 
                                                     accounts 
                                                        $'000 
 
Balance as of 1 January, 2007                             179 
Provision, net of recoveries                               64 
Write-off                                               (112) 
 
Balance as of 31 December, 2007                           131 
Provision, net of recoveries                              331 
Write-off                                                   - 
 
Balance as of 31 December, 2008                           462 
 
 
Impaired debts are accounted for through recording an allowance for doubtful 
accounts. 
 
NOTE 4:- Intangible Assets 
 
                                       Core   Developed 
                                 technology  technology   Total 
 
                                      $'000       $'000   $'000 
Cost: 
 
At 1 January 2007                       577         648   1,225 
 
At 31 December 2007                     577         648   1,225 
Disposals                                 -        (21)    (21) 
 
At 31 December 2008                     577         627   1,204 
 
Amortization and impairment: 
 
At 1 January 2007                       125         206     331 
Amortization                             82         162     244 
 
Balance at 31 December 2007             207         368     575 
Disposals                                 -        (15)    (15) 
Amortization                             82         162     244 
 
At 31 December 2008                     289         515     804 
 
Net book value: 
At 31 December 2008                     288         112     400 
 
At 31 December 2007                     370         280     650 
 
At 1 January 2007                       452         442     894 
 
 
Amortization expense is recorded in cost of sales. 
 
During 2008, EVC has entered into an agreement to sell certain of 
its patents to Handheld Devices in consideration of $ 3,200 in cash. EVC 
received out of the consideration $ 1,622, net of payments to the Office of 
the Chief Scientist of the Ministry of Industry and net of commissions payable 
to a firm of patent attorneys, which introduced the buyer to EVC, and 
associated legal fees. 
 
NOTE 5: - Income Taxes 
 
a. Israeli taxation: 
 
1. Corporate tax rate: 
 
On 25 July 2005, the Israeli Parliament approved an amendment to 
the Income Tax Ordinance (No. 147) 2005, which prescribes, among others, a 
gradual decrease in the corporate tax rate in Israel to the following tax 
rates: in 2008 - 27 per cent., in 2009 - 26 per cent., 2010 and thereafter - 
25 per cent. 
 
2. EVC submitted an application to assign the programs of VCON 
under the Law for the Encouragement of Capital Investments, 1959 ("the Law") 
to EVC and thus enjoy the tax benefits (primarily reduced tax rates) of an 
"Approved Enterprise" as defined by the Law. The application was approved by 
the Israel Investment Center (a department of the Ministry of Industry, Trade 
and Labor). 
 
The Company's production facilities in Israel have been granted 
"Approved Enterprise" status, for 6 investment programs approved under the 
Law. According to the provisions of the Law, the Company has elected the 
"alternative benefits" track, the waiver of grants in return for a tax 
exemption and, accordingly, the Company's income from the "Approved 
Enterprise" is tax exempt for a period of two years commencing with the year 
it first earns taxable income and afterwards is entitled to a reduced tax rate 
of 10 per cent to 25 per cent for an additional period of five to eight years 
(depending on the level of foreign investment in the Company). 
 
The entitlement to the above benefits is conditional upon the 
fulfillment of the conditions stipulated by the above Law, regulations 
published there under and the letters of approval for the specific investments 
in "Approved Enterprises". In the event of failure to comply with these 
conditions, the benefits may be cancelled and the Company may be required to 
refund the amount of the benefits, in whole or in part, including interest. 
 
The period of tax benefits, detailed above, is subject to limits of 
the earlier of 12 years from the commencement of production, or 14 years from 
the approval date. These limitation do not apply to the tax exempt period of 
the first two years. 
 
Income from sources other than the "Approved Enterprise" during the 
benefit period will be subject to tax at the regular corporate tax rate. 
 
3. On 1 April 2005, an amendment to the Investment Law came into 
effect ("the Amendment") and has significantly changed the provisions of the 
Investment Law. The Amendment limits the scope of enterprises which may be 
approved by the Investment Center by setting criteria for the approval of a 
facility as an Approved Enterprise, such as provisions generally requiring 
that at least 25 per cent. of the Approved Enterprise's income will be derived 
from export. Additionally, the Amendment enacted major changes in the manner 
in which tax benefits are awarded under the Investment Law so that companies 
no longer require Investment Center approval in order to qualify for tax 
benefits. 
 
4. However, the Investment Law provides that terms and benefits 
included in any letter of approval already granted will remain subject to the 
provisions of the law as they were on the date of such approval. Therefore the 
Israeli subsidiary's existing Approved Enterprise will generally not be 
subject to the provisions of the Amendment. 
 
EVC is an "industrial company" under the Law for the Encouragement 
of Industry (Taxation), 1969 and as such is entitled to certain tax benefits, 
including a reduction in the purchase price for patents or certain other 
intangible property rights at the rate of 12.5 per cent. per year beginning 
with the first year the Company used such intangible property rights and the 
deduction of public offering expenses over three years. 
 
b. Carry forward tax losses: 
 
As of 31 December 2008, the Company has carry forward tax losses of 
approximately $ 11,000 (2007: approximately $ 11,000) that can be carried 
forward indefinitely. 
 
As of 31 December 2008, EVC has carry forward tax losses of 
approximately $ 7,800 (2007: approximately $ 5,000) that can be carried 
forward indefinitely. 
 
As of 31 December 2008, the U.S. subsidiary had U.S. federal carry 
forward tax losses of approximately $ 4,700 (2007: $ 4,900) that can be 
carried forward and offset against taxable income for 15-20 years and expire 
between 2020 and 2025. 
 
Management currently believes that since the Company and its 
subsidiaries have no history of ongoing profits it is not probable that the 
deferred tax asset in respect of the loss carry forwards and other temporary 
differences, in the amount of $ 2,034 (2007 - $ 2,013), mainly due to research 
and development differences, will be realized. 
 
c. Tax assessments: 
 
The Company received final tax assessments through 2004. 
 
NOTE 6: - Related Party Disclosure 
 
a. Compensation of key management personnel of the Group: 
 
                                               31 December, 
                                             2008        2007 
 
                                            $'000       $'000 
 
Short-term employee benefits                  158         308 
Severance pay                                   -          18 
Share-based payments                            -          61 
 
Total compensation paid to key 
management personnel                          158         387 
 
 
Directors' interests in an employee stock option plan: 
 
Share options held by executive members of the Board of Directors 
to purchase ordinary shares have the following expiry dates and exercise 
prices: 
 
                                 Exercise 
Issue date     Expiry date          price         2008         2007 
                                                Number       Number 
                                           outstanding  outstanding 
 
2006                  2016          $0.44      250,000      250,000 
2007                  2017          $0.49    1,278,006    1,278,006 
 
 
No share or options have been granted to the non-executive members 
of the Board of Directors under this scheme. 
 
b. Entities with significant influence over the Group: 
 
Emblaze Ltd. owns 64.88 per cent. of the ordinary shares in Zone IP 
Ltd. 
 
Transactions 
 
                                          Year ended 
                                          31 December, 
 
                                       2008         2007 
 
                                      $'000        $'000 
 
Rent and utilities expenses             146           80 
c. Balances 
 
Amount owed to Emblaze at 31 December 2008 and 2007 was $ nil and 
$53, respectively. 
 
d. During December 2008, the Company received a loan in the amount 
of $ 1,282 from certain of the Company's controlling shareholders ("lenders"). 
The loan does not bear any interest and will be repaid to the lenders five 
years following the effective date. The Company recorded a capital reserve in 
the amount of $ 250 in respect with the loan received from the lenders. 
 
NOTE 7:- Dividends 
 
No dividends have been declared for the year ended 31 December 2008. 
 
NOTE 8:- Copies of the Report and Accounts will be sent to shareholders in due 
course and will be available from the Company's website at www.zone-ip.com. 
 
 
END 
 

Zone-ip (LSE:ZIP)
Graphique Historique de l'Action
De Nov 2024 à Déc 2024 Plus de graphiques de la Bourse Zone-ip
Zone-ip (LSE:ZIP)
Graphique Historique de l'Action
De Déc 2023 à Déc 2024 Plus de graphiques de la Bourse Zone-ip